Dr.Salih Al-hasnawi
Minister of health
Dear Colleagues,
Under the patronage of the prime minister and on behalf of the Ministry Of Health and The Iraqi Cancer Board, It is our pleasure to invite you to attend the 1st Iraqi Cancer Board conference , which will be held on October 5-6, 2023 at Dijlah Village, Baghdad.
This conference will attract hundreds of delegates from related backgrounds , including healthcare providers, scientists, investors and business owners, international and local pharmaceutical companies regional and international representatives, as well as an outstanding group of high-profile international & regional speakers that will cover the topics above.
The 1st Iraqi cancer board conference will provide attendees with a brief about the vision of the ministry of health regarding developing the oncology healthcare services provided in governmental and private hospitals. The 1st Iraqi cancer board conference will be repeated annually, aiming to become the foremost scientific destination for oncology healthcare providers and industry from Iraq and the region. We look forward to welcome you in the 1st Iraqi cancer board conference.
Sincerely Yours,
Head of scientific & organizing committee
Dr.Monawer Abdulelah Al-Naqash
- Dr.Haider Noman
- Dr.Ashraf Fareed Sayhood
- Dr.Sherin Ali Hussein
- Dr.Sura Yassin Abd
- Dr.Rasha Zaki
- Local pharmaceutical and medical equipment manufacturing for cancer care.
- List of essential and other drugs for oncology patients management.
- Health insurance for cancer patients.
- Biosimilar drugs.
- Developing local guidelines for different types of cancers.
- Analyzing current practice against international standards in cancer management.
- Evaluatimg opportunities in enhancing cancer care in Iraq.
- Surgical oncology and postoperative care.
- Screening and early detection of cancer.
- Cancer registry and national ID for cancer patients.
- Latest updates in cancer management.
- Clinical research in oncology.
Deadline: 1st of August 2023
- The 1st Iraqi Cancer Board Conference 2023 will be an in- person conference; authors must attend and present at the conference in-person.
- Papers may have multiple authors; at least one author must register for and attend the conference.
- The submitting author should input all author details and upload their abstract using the the abstract submission form.
- All abstracts must be submitted in English.
- Submissions should use 12 pt font, and follow APA-7 style guide from Here.
